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Abstract
We have previously described the occurrence of multiple sclerosis (MS) to be associated with human endogenous
retroviruses, specifically the X-linked viral locus HERV-Fc1. The aim of this study was to investigate a possible association of
the HERV-Fc1 locus with subtypes of MS. MS patients are generally subdivided into three categories: Remitting/Relapsing
and Secondary Progressive, which together constitute Bout Onset MS, and Primary Progressive. In this study of 1181 MS
patients and 1886 controls we found that Bout Onset MS was associated with the C-allele of the marker rs391745 near the
HERV-Fc1 locus (p=0.003), while primary progressive disease was not. The ability to see genetic differences between
subtypes of MS near this gene speaks for the involvement of the virus HERV-Fc1 locus in modifying the disease course of
MS.
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Introduction
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating
disease of the central nervous system probably caused by interaction
of multiple genes and environmental factors [1]. HLA genes are the
most strongly associated genes in MS [2], and low Vitamin D level
in serum, Epstein Bar Virus infection and smoking are currently the
best documented environmental risk factors [3,4].
An involvement of retroviruses has also long been suspected [5].
Originally, this was based on animal models, where other
demyelinating diseases could be induced by retroviruses [6,7,8].
However, these animal diseases are all contagious and horizontally
transmitted, and MS does not seem to be transferred in this
manner. Therefore, some scientists have focused their research on
endogenous retroviruses that are vertically transmitted from
parents to offspring as part of the chromosomes. Attempts at
isolating such viruses from patients with MS have been partial
successful [9,10]. The main difficulty of the latter studies, apart
from the technical challenges, is the inadequacy of Koch’s
postulates for dealing with ubiquitous agents. Koch’s postulates
are the criteria traditionally required to be fulfilled in order to
establish a causal relationship between a microbe and a disease,
and contain the implicit assumption that most people are free of
the microbe. The postulates fail, when the microbe is universally
present, which is the case with most endogenous viral loci.
Recently, we described the occurrence of MS to be associated
with human endogenous retroviruses [11]. The interpretation of
these findings did not involve Koch’s postulates, but depended on
the theories of genetics. We found association of MS with alleles of
the host gene TRIM5 that restricts the replication of a broad
variety of retroviruses. This suggested retroviral replication to be
involved in this disease, but did not indicate which virus. Hence,
we also looked for association of specific endogenous retroviruses
with MS. We found an association of MS with markers in and
near the endogenous retroviral locus HERV-Fc1, located on the
X-chromosome [12]. The associations could be reproduced in
several cohorts, encompassing a total of 1060 cases and 2080
controls [11]. The results suggested the involvement of HERV-Fc1
in MS. In addition, we have recently found that expression of
HERV-Fc1 RNA is approximately 4-fold higher in plasma from
MS patients with recent attacks, compared to plasma from patients
in stable remission and from controls [13]. This provides a possible
new biomarker and may give clues to further studies of the
pathogenic process in MS.
The association of the HERV-Fc1 locus with the clinical course
of MS has not been studied previously. MS patients are clinically
subdivided into three categories: Remitting/Relapsing MS
(RRMS), Secondary Progressive MS (SPMS), and Primary
Progressive MS (PPMS). RRMS and SPMS are generally
considered time-wise progressions of the same disease, altogether
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the patients (85–90%), while PPMS is characterized by a separate
disease entity with disease progression from onset (10–15%). In
this paper, encompassing 1181 MS cases and 1886 controls from
one new (Norwegian) and one previously examined cohort
(Danish), we report that BOMS is associated with a marker near
the HERV-Fc1 locus, while PPMS disease is not.
Materials and Methods
Ethical approval
Collection of blood samples from MS patients and blood donors
for genetic investigations was approved by the Regional Ethics
committee (Norway) and local Science Ethical Committees
(Denmark). The patients gave written informed consent.
Clinical data
The sub-typing of the patients was based on clinical data using
the criteria of Poser [14].
Analysis
DNAs were extracted from the blood by conventional means.
The DNAs were genotyped for the rs391745 single nucleotide
polymorphism (SNP) located near the X-linked viral locus HERV-
Fc1 on a mass spectrometry SequenomH facility using Gold
plex reactions (Sequenom, San Diego, CA). The analysis was
performed as previously described [11], using the following
sequenom primers; rs391745_PCR1: ACGTTGGATGTAAAA-
TATGTGCCCACCCTC; rs391745_PCR2: ACGTTGGATG-
GATTCTCAGCATGGACCATC and the rs391745 probe
ggtgCAGCATGGACCATCTCTTCAG.
Statistics
The data were analyzed in IBM SPSS version 19 and Excel
2007 (Microsoft, Redmond, WA). For a minority of persons, no
subtype or gender information was available, or the typing of
rs391745 failed. The main statistic tests performed were x
2 tests.
To combine p-values we used Fisher’s method: x
2 (P, 2n)=22S ln
(pi), where P is the combined two-sided p-value and pi are the n
one-sided p-values to be combined.
Results and Discussion
We analyzed two cohorts of MS patients: 544 cases and 1142
controls from Denmark, and 637 cases and 744 controls from
Norway. The Danish cohort was also included in a previous study
[11]. Information about individual subtypes of MS had been
collected for most patients in both cohorts.
In the previous analysis, the best marker in or near the HERV-
Fc1 locus for association with MS was rs391745. Table 1 shows
the association of MS and subtypes of MS with rs391745 in the
two cohorts. Both cohorts showed an association of the C-allele of
the rs391745 SNP in the total MS group (p=0.003). The
overrepresentation of C-alleles among cases corresponds to what
was observed previously and extends previous findings to a larger
set of patients. BOMS also showed a significant association to the
C-allele of this SNP (p=0.003). In contrast, PPMS was not
associated with any allele of rs391745. This lack of association was
present in both cohorts and was emphasized when the cohorts
were combined.
To make sure gender issues did not perturb the results, we also
performed a gender-stratified analysis of the combined cohorts.
The conclusions were the same: BOMS was associated with
HERV-Fc1, PPMS was not (Table S1). The p-values were higher,
but this was to be expected as the stratified analysis does not
contain any cross comparisons: male cases versus female controls
and vice versa and thus has less strength.
Three arguments strengthen the tie between MS and HERV-
Fc1. First, the association of MS with markers on the X-
chromosomal region is limited to an approximately 20 kb region,
which includes HERV-Fc1. There are no other known genes in
this region [11]. Secondly, the restriction gene TRIM5, which is
known to limit retroviral replication, influences the risk of getting
MS [11]. Finally, we have found that expression of HERV-Fc1
RNA is four-fold increased in the plasma of MS patients with a
recent history of an attack, relative to patients in stable remission
and to controls [13]. We take all these data as indications that














Danish All cases 102 431 0.19 1.35(1.03–1.75) 0.03
PPMS 4 29 0.12 0.79 (0.27–2.26) 0.7
BOMS 86 359 0.19 1.36 (1.02–1.81)) 0.03
Controls 166 945 0.15
Norwegian All cases 105 522 0.17 1.35 (1.00–1.83) 0.05
PPMS 16 91 0.15 1.18 (0.67–2.10) 0.6
BOMS 85 411 0.17 1.39 (1.01–1.92) 0.04
Controls 94 633 0.13
Combined All cases 207 953 0.18 1.32 (1.08–1.61) 0.003
PPMS 20 120 0.14 1.01 (0.62–1.6) 0.96
BOMS 171 770 0.18 1.35 (1.09–1.67) 0.003
Controls 260 1578 0.14
Of the persons 70 failed determination of rs391745, and 59 lacked information of MS subtype.
1OR: oddsratio for C-allele carriers vs C-allele noncarriers.
2CI95%: 95 percent confidence interva.
doi:10.1371/journal.pone.0026438.t001
Subtypes of MS and Genetic Association to HERV-Fc1
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e26438development of BOMS may be influenced by the endogenous
retrovirus locus HERV-Fc1.
Another corroboration to this conclusion stems from the
observation that PPMS has a gender-ratio close to one [15]. This
is in contrast to the near 2:1 ratio observed for BOMS. This
difference in gender ratio was to be expected if HERV-Fc1,
located on the X-chromosome, plays a role in BOMS but not in
PPMS.
It seems reasonable to speculate on the importance of HERV-
Fc1 for disease. If we take the epidemiological approach and
assume that rs391745 is the causative variation, we arrive at an
etiological fraction of 0.05 to 0.1, i.e. rs391745 is a minor risk
determinant for BOMS. Alternatively, if we take the genetic view
that rs391745 is a marker in linkage disequilibrium with the true
causative variation, the etiological fraction of the latter variation
should be higher and the virus could in principle be a primary
cause of BOMS. With the latter optimistic view in mind, we are
searching for markers with better association to BOMS in and
around HERV-Fc1.
Recently, a large genome-wide association study (GWAS) of MS
identified an excess of fifty different genes statistically associated to
MS [16]. An overrepresentation was observed of genes related to
the immune system. This GWAS did not identify association to the
HERV-Fc1region, but this is not in conflict with the HERV-Fc1
data presented here.
In conclusion, this study suggests a molecular distinction of
different disease courses in MS by involvement of HERV-Fc1.
This warrants further investigations.
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